Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
7 Dividend Stocks to Buy as Investor Sentiment Falters
03:38pm, Monday, 14'th Aug 2023
While optimism in the broader market remains robust – particularly for hyped-up sectors like technology – investors may still want to consider the relative safety of dividend stocks to buy. Notabl
5 Best Stocks to Buy in a Bear Market
01:49pm, Saturday, 12'th Aug 2023
In the ever-fluctuating stock market landscape, navigating bear markets can be a nerve-wracking experience for even the most seasoned investors. When stock prices plunge and economic clouds gather, it
3 Pharmaceutical Stocks to Buy and Hold for the Long Haul
01:48pm, Saturday, 12'th Aug 2023
There's a reason why many investors own one or more pharmaceutical stocks. This is a $1.2 trillion industry that is essential to the quality of life for many people.
3 Unstoppable Dividend Stocks to Buy Right Now
06:15am, Saturday, 12'th Aug 2023
AbbVie is more unstoppable than you might think. Johnson & Johnson faces some challenges but remains a solid pick for long-term investors.
3 Pharma Stocks to Sell in August Before They Crash and Burn
08:52pm, Friday, 11'th Aug 2023
With pharmaceutical companies, it's all about the pipeline of new medications. Drugmakers, and their pharma stocks, are judged based on sales of current medications and potential sales of future presc
3 Dividend Aristocrat Buys For August And 6 To Watch
08:22am, Friday, 11'th Aug 2023
"Dividend Aristocrats in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years. " - Kiplinger.com/Investing. 66 Aristocrats, screened as of August 9, 2023, re
3 Stocks That Recently Raised Their Guidance for the Year
10:23am, Wednesday, 09'th Aug 2023
AbbVie, Coca-Cola, and DoorDash are coming off better-than-expected quarters. These three companies all all feeling more optimistic about the rest of 2023.
Is AbbVie Still a Good Dividend Stock to Buy?
05:37am, Tuesday, 08'th Aug 2023
AbbVie's top-selling drug, Humira lost patent-protected market exclusivity in the U.S. this year. AbbVie offers an above-average dividend yield because investors are concerned that sinking Humira sale
Is AbbVie Stock a Buy for Income Investors?
08:19am, Friday, 04'th Aug 2023
Humira's loss of exclusivity pressured sales and profits in Q2, but there were positive signs to be found. The company's market-beating payout should remain viable.
Abbott Labs Vs AbbVie: Which One Is The Best Investment Choice?
05:48pm, Thursday, 03'rd Aug 2023
Abbott Labs spun off AbbVie in 2013. AbbVie has lost patent protection on its largest selling product Humira. AbbVie has better financial metrics and dividends.
Sell Alert: 3 Healthcare Stocks to Dump ASAP
06:00am, Thursday, 03'rd Aug 2023
Healthcare stocks are generally thought of as safe or even recession-proof investments. This is because the underlying companies provide essential products and services that are required no matter wha
Better High-Yield Dividend Stock: AbbVie vs. Verizon Communications
04:45pm, Tuesday, 01'st Aug 2023
AbbVie and Verizon Communications are two popular high-yield dividend stocks. However, one stock is clearly a better passive income vehicle.
Buy 5 August Dividend Kings, Watch 4 More
04:22pm, Tuesday, 01'st Aug 2023
"There is only one-criterion to be included among the Dividend Kings: a publicly-traded company must increase its total fiscal-year dividend-payout for a minimum of 50 consecutive-years."--Dogs of the
3 Magnificent High-Yield Dividend Stocks to Buy Hand Over Fist in August
05:50am, Tuesday, 01'st Aug 2023
AbbVie is a Dividend King that is navigating some headwinds better than expected. Brookfield Renewable stands to profit with a brighter spotlight on carbon emissions reduction.
The Patent Cliff Is Why AbbVie Is Moving Higher
07:09am, Friday, 28'th Jul 2023
AbbVie NYSE: ABBV shares have been under pressure for the last 2 years as fears of the patent cliff gripped the market. The fear of rapidly declining Humira sales was not offset by hope driven by new
